• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

PFE:US

31.6500 USD 0.2300 0.73%

As of 20:04:04 ET on 12/26/2014.

Snapshot for Pfizer Inc (PFE)

Open: 31.5000 Day's Range: 31.3000 - 31.8400 Volume: 8,606,413
Previous Close: 31.4200 52wk Range: 27.5100 - 33.1154 1-Yr Rtn: +6.96%

Stock Chart for PFE

No chart data available.
  • PFE:US 31.6500
  • 1D
  • 1M
  • 1Y
31.4200
Interactive PFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PFE

Current P/E Ratio (ttm) 17.0257
Estimated P/E(12/2014) 14.0854
Relative P/E vs. SPX 0.9204
Earnings Per Share (USD) (ttm) 1.8590
Est. EPS (USD) (12/2014) 2.2470
Est. PEG Ratio 6.1241
Market Cap (M USD) 199,415.80
Shares Outstanding (M) 6,300.66
30 Day Average Volume 24,661,356
Price/Book (mrq) 2.5580
Price/Sale (ttm) 4.0371
Dividend Indicated Gross Yield 3.54%
Cash Dividend (USD) 0.2800
Dividend Ex-Date 02/04/2015
5 Year Dividend Growth 5.39%
Next Earnings Announcement 01/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PFE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PFE

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

Ian C ReadChairman/CEOGeno J GermanoChief Innovation Officer
Albert BourlaPres:Vaccines & OncologyMikael DolstenPres:Worldwide Research & Dev
More Company Profile & Key Executives for PFE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil